Please assess the completion status of the following clinical trial:

Trial Title: Effect Of Ophiochepalus Striatus Extract On Serum IGF-1 And IL-6 Levels In Elderly Patients With Sarcopenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elderly patients with sarcopenia diagnosed using AWGS criteria consist of low muscle mass: using the BIA examination tool where men: \<7.0kg/m2, women: \<5.7kg/m2 plus low muscle strength using a handgrip dynamometer, men: \<28kg , female : \<18kg or low physical performance using the 6 meter walk test; \<1 meter/second.~Exclusion Criteria:~* Chronic liver disease (cirrhosis of the liver) or severe liver dysfunction or increased SGPT\> 3 times the upper limit of normal value~* Impaired kidney function with a glomerular filtration rate \<30 ml/minute without hemodialysis~* Acute phase of illness (eg infection, acute arthritis, acute stroke, trauma)~* Malignancy~* Depression according to the geriatric depression scale (Geriatric Depression Scale score\> 10)~* History of hypersensitivity to Ophiocephalus striatus~* Refuse to participate in research

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Control group get placebo 2x5 grams a day for 14 days
- Ophiochepalus striatus extract (Type: EXPERIMENTAL): Intervention group get Ophiochepalus striatus extract 2x5 grams a day for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).